Sam Chun Dang Pharm. Co.,Ltd

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Takeda Partners With LegoChe

Alteogen Inc. has filed an IND to begin clinical trials with its biosimilar version of Eylea (aflibercept) in South Korea, moving forward with its plan to become a global first mover for the biosim

You probably can’t say that the Indo-South Korean pharma corridor is abuzz with activity yet, but there are certainly early signs of exploratory bonhomie between drug firms in the two Asian nations. A

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in